Arguments in favour of excluding MDBGN from the European baseline series. In response to "Comment on MDBGN/DBDCB, the European baseline series, and EU legislation"

Mostra el registre complet Registre parcial de l'ítem

• dc.contributor.author Mercader García, Pedro
• dc.contributor.author Pastor-Nieto, María
• dc.contributor.author González-Pérez, Ricardo
• dc.contributor.author Giménez Arnau, Anna Maria
• dc.contributor.author Ruiz-Gonzalez, Inmaculada
• dc.contributor.author Mora-Fernández, Verónica
• dc.contributor.author Miquel, Javier
• dc.contributor.author Silvestre Salvador, Juan Francisco
• dc.contributor.author Sanz-Sánchez, Tatiana
• dc.contributor.author Perez-Feal, Patricia
• dc.contributor.author Sánchez-Pérez, Javier
• dc.contributor.author Heras-Mendaza, Felipe
• dc.contributor.author Serra-Baldrich, Esther
• dc.contributor.author Hervella Garcés, Marcos
• dc.contributor.author Gatica-Ortega, María-Elena
• dc.contributor.author García-Doval, Ignacio
• dc.contributor.author Borrego, Leopoldo
• dc.date.accessioned 2022-01-18T06:52:35Z
• dc.date.issued 2021
• dc.format.mimetype application/pdf
• dc.identifier.citation Mercader-García P, Pastor-Nieto MA, Gonzalez-Perez R, Gimenez-Arnau AM, Ruiz-Gonzalez I, Mora-Fernández V, Miquel J, Silvestre-Salvador JF, Sanz-Sanchez T, Perez-Feal P, Sánchez-Pérez J, Heras-Mendaza F, Serra-Baldrich E, Hervella-Garces M, Gatica-Ortega ME, García-Doval I, Borrego L. Arguments in favour of excluding MDBGN from the European baseline series. In response to "Comment on MDBGN/DBDCB, the European baseline series, and EU legislation". Contact Dermatitis. 2021;85(5):611-3. DOI: 10.1111/cod.13941
• dc.identifier.doi http://dx.doi.org/10.1111/cod.13941
• dc.identifier.issn 0105-1873
• dc.identifier.uri http://hdl.handle.net/10230/52245
• dc.language.iso eng
• dc.publisher Wiley
• dc.relation.ispartof Contact Dermatitis. 2021;85(5):611-3
• dc.rights This is the peer reviewed version of the following article: Mercader-García P, Pastor-Nieto MA, Gonzalez-Perez R, Gimenez-Arnau AM, Ruiz-Gonzalez I, Mora-Fernández V, Miquel J, Silvestre-Salvador JF, Sanz-Sanchez T, Perez-Feal P, Sánchez-Pérez J, Heras-Mendaza F, Serra-Baldrich E, Hervella-Garces M, Gatica-Ortega ME, García-Doval I, Borrego L. Arguments in favour of excluding MDBGN from the European baseline series. In response to "Comment on MDBGN/DBDCB, the European baseline series, and EU legislation". Contact Dermatitis. 2021;85(5):611-3. DOI: 10.1111/cod.13941, which has been published in final form at http://dx.doi.org/10.1111/cod.13941. This article may be used for non-commercial purposes in accordance with Wiley Terms and Conditions for Use of Self-Archived Versions.
• dc.rights.accessRights info:eu-repo/semantics/openAccess
• dc.subject.keyword Allergic contact dermatitis
• dc.subject.keyword Epidemiology
• dc.subject.keyword Methyldibromo glutaronitrile
• dc.title Arguments in favour of excluding MDBGN from the European baseline series. In response to "Comment on MDBGN/DBDCB, the European baseline series, and EU legislation"
• dc.type info:eu-repo/semantics/article
• dc.type.version info:eu-repo/semantics/acceptedVersion